Winsantor
WinSanTor is a clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo-induced peripheral neuropathy and HIV-induced peripheral neuropathy.
DeepWEBSITE ↗
Why it's on the radar
TeamFundraising signals (who's likely raising, and why) are on Team.Start a free 14-day trial →Funding history · 0 rounds
No rounds on record yet.
Key people
ProKey people, exec moves and open roles are on Pro.Start a free 14-day trial →